Tenderwize
Back to tender search

Open House Discount Agreements for Active Substance Molsidomin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 227 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Molsidomin, ATC C01DX12

75/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

75 / 100

Complexity

25 / 100

Risk factors

The buyer reserves the right to replace Open House agreements with exclusive contracts from future tenders at any time...

No estimated value is provided. Revenue depends entirely on actual prescriptions and market share. No minimum quantity...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for pharmaceutical products with active substance Molsidomin (ATC C01DX12)
  • Supply of authorized and marketable drugs in Germany
Show full summary

This is an Open House procedure for non-exclusive discount agreements (Rabattverträge) for pharmaceutical products containing the active substance Molsidomin (ATC C01DX12). The contracting authority is AOK Rheinland-Pfalz/Saarland. All interested pharmaceutical companies can join without selection. Contracts run for a maximum of 24 months (from 01.06.2025 to 31.05.2027) and can be terminated with 6 weeks' notice. The Open House may be replaced at any time by exclusive contracts from tendered procedures. Initial submission deadline for the first contract start (01.06.2025) is 30.04.2025; later entries are possible monthly. No estimated contract value is provided. The notice explicitly states that this is not a public procurement under EU law but published voluntarily for transparency.

Risks

The buyer reserves the right to replace Open House agreements with exclusive contracts from future tenders at any time...

No estimated value is provided. Revenue depends entirely on actual prescriptions and market share. No minimum quantity...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Proof of marketability via Lauer-Taxe listing or AMIce database extracts

Eligibility

  • Only authorized and marketable drugs in Germany are eligible

Administrative

  • Signed contract documents must be submitted in original (electronic submission not allowed)

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria – open house with no selection; all eligible participants are accepted.

Buyer

Lots (1)

LOT-0001

Open House Discount Agreements for Active Substance Molsidomin

Non-exclusive discount agreements for Molsidomin (ATC C01DX12) products. All pharmaceutical companies meeting eligibility can join. Contracts run up to 24 months, starting from 01.06.2025. No selection or negotiation; uniform terms for all participants. The buyer may replace these agreements with exclusive contracts from future tenders, leading to automatic termination.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No award criteria – open house with no selection; all eligible participants are accepted.

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
236173-2025

Documents (1)

Similar tenders